Medicare Enrolled

Dr. Kumar Gutta, M.D.

Gastroenterology · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
900 W MAGNOLIA AVE, Fort Worth, TX 76104
8178707300
In practice since 2005 (20 years)
NPI: 1831180413 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gutta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gutta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gutta

Dr. Kumar Gutta is a gastroenterology in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Gutta performed 7,040 Medicare services across 939 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gutta received a total of $16,423 from 53 pharmaceutical and/or device companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gutta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 1% volume in TX$ $16,423 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,040
Medicare services
Top 1% in TX for gastroenterology
939
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~352 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Vedolizumab infusion (Entyvio)6,000$17$68
Office visit, established patient (30-39 min)268$88$217
Removal of polyps or growths of large bowel using an endoscope with mechanical snare153$204$1,067
Upper GI endoscopy with biopsy141$54$680
Office visit, established patient (20-29 min)87$65$148
New patient office visit (45-59 min)84$113$332
Hospital follow-up visit, moderate complexity73$62$146
New patient office visit (30-44 min)51$57$219
Colonoscopy with biopsy44$72$847
Insertion of guide wire with dilation of esophagus using a flexible endoscope37$91$701
Colorectal cancer screening; colonoscopy on individual at high risk26$171$778
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less20$50$146
Initial hospital admission, moderate complexity18$97$278
New patient office or other outpatient visit, 15-29 minutes14$40$151
Initial hospital admission, high complexity13$135$411
New patient office visit, complex (60-74 min)11$124$418
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
85.5% high complexity
3.0% medium
11.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,423
Total received (2018-2024)
Avg $2,346/year across 7 years
Top 12% in TX for gastroenterology
53
Companies
640
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,545 (88.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,616 (9.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$263 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,030
2023
$4,639
2022
$1,949
2021
$990
2020
$410
2019
$1,182
2018
$3,224

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GastroGPO, LLC
$1,971
ABBVIE INC.
$1,755
Shionogi Inc
$1,672
Janssen Biotech, Inc.
$1,525
Boston Scientific Corporation
$1,139
AbbVie, Inc.
$1,062
Takeda Pharmaceuticals U.S.A., Inc.
$678
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$652
Celgene Corporation
$547
Enterra Medical, Inc.
$521
PFIZER INC.
$449
AbbVie Inc.
$391
Regeneron Healthcare Solutions, Inc.
$293
Ferring Pharmaceuticals Inc.
$266
QOL Medical, LLC
$265
Lilly USA, LLC
$221
VIVUS LLC
$183
Organon LLC
$179
Covidien LP
$170
GENZYME CORPORATION
$169
Daiichi Sankyo Inc.
$168
E.R. Squibb & Sons, L.L.C.
$152
RedHill Biopharma Inc.
$152
BOSTON SCIENTIFIC CORPORATION
$149
Ardelyx, Inc.
$133
Ironwood Pharmaceuticals, Inc
$128
Merck Sharp & Dohme LLC
$120
Cook Medical LLC
$118
IRONWOOD PHARMACEUTICALS, INC
$111
Amgen Inc.
$105
Intercept Pharmaceuticals, Inc.
$103
Braintree Laboratories, Inc.
$96
Janssen Scientific Affairs, LLC
$86
INTERCEPT PHARMACEUTICALS, INC.
$74
Merck Sharp & Dohme Corporation
$67
Ethicon US, LLC
$62
NESTLE HEALTHCARE NUTRITION INC.
$54
Gilead Sciences, Inc.
$48
UCB, Inc.
$47
Allergan Inc.
$46
Fresenius Kabi USA, LLC
$36
AIMMUNE THERAPEUTICS, INC.
$35
Nestle HealthCare Nutrition Inc.
$29
Pharmacosmos Therapeutics Inc.
$28
Ipsen Biopharmaceuticals, Inc
$28
Mauna Kea Technologies, Inc.
$23
Romark Laboratories, LC
$21
Evoke Pharma, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Organon Llc
$15
Madrigal Pharmaceuticals
$15
AstraZeneca Pharmaceuticals LP
$15
Synergy Pharmaceuticals Inc
$11
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Alinia Tablets 500mg 30 count bottle · Bylvay · CLENPIQ · COOK MEDICAL HEMOSPRAY · CRE PRO · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Epclusa · GATTEX · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · IQIRVO · LINX Reflux Management System · LINZESS · Linzess · MONOFERRIC · MOVANTIK · Mavyret · Motegrity · Mulpleta · OCALIVA · OMVOH · PANCREAZE · PillCam · QSYMIA · REBYOTA · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · VELSIPITY · VIBERZI · Viekira · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $233 per 100 Medicare services performed
Looking for a gastroenterology in Fort Worth?
Compare gastroenterologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
124
Per 100K population
5.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gutta is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gutta experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Gutta performed 6,000 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gutta receive payments from pharmaceutical companies?
Yes. Dr. Gutta received a total of $16,423 from 53 companies across 640 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gutta's costs compare to other gastroenterologys in Fort Worth?
Dr. Gutta's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gutta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →